[Drug-induced lymphadenitis].
Yin
Wei-hua
WH
weihuayin@sina.com
Zhang
Hong-yu
HY
Li
Xue-feng
XF
Ma
Ya
Y
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D017252:CD3 Complex / Q000378:metabolism; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000378:metabolism / Q000473:pathology; D017730:Ki-1 Antigen / Q000378:metabolism; D008199:Lymphadenitis / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000378:metabolism / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000378:metabolism / Q000473:pathology; D017464:Receptors, Complement 3d / Q000378:metabolism; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D017252:CD3 Complex; D005765:Gastrointestinal Agents; D017730:Ki-1 Antigen; D017464:Receptors, Complement 3d; D012460:Sulfasalazine